ArticleAmerican journal of cancer research2026
Efficacy of tislelizumab combined with nab-paclitaxel and nedaplatin in advanced esophageal squamous cell carcinoma and its impact on serum tumor markers.
Rongzhi Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.